Synergistically improved cardiovascular outcomes in type 2 diabetes mellitus patients with combined treatment of SGLT-2 inhibitors and pioglitazone
In T2DM patients without HF, the combined treatment with SGLT2i and Pio may synergistically provide CV benefits without increasing risks of HF.
Authors
- Victor Chien‐Chia Wu (ORCID: https://orcid.org/0000-0002-9918-4369)
- Ching-Chung Hsiao (ORCID: https://orcid.org/0000-0003-3782-8189)
- Ching‐Yu Lee (ORCID: https://orcid.org/0000-0001-6118-1667)
- Chi‐Hung Liu (ORCID: https://orcid.org/0000-0001-8965-2096)
- Chih‐Ching Wang
- Yanrong Li (ORCID: https://orcid.org/0000-0002-0206-3473)
- Chieh-Li Yen
- Evelyn Jou-Chen Huang
Institutions
- Chang Gung University (TW)
- National Tsing Hua University (TW)
- Taipei Medical University Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.3389/fendo.2024.1420485
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Chang Gung Medical Foundation